Drug Shortage Report for TARO-ZOLEDRONIC ACID CONCENTRATE
| Report ID | 82629 |
| Drug Identification Number | 02415186 |
| Brand name | TARO-ZOLEDRONIC ACID CONCENTRATE |
| Common or Proper name | TARO-ZOLEDRONIC ACID CONCENTRATE |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | ZOLEDRONIC ACID |
| Strength(s) | 4MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 5ml |
| ATC code | M05BA |
| ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-04-26 |
| Estimated end date | 2019-06-28 |
| Actual end date | 2019-06-07 |
| Shortage status | Resolved |
| Updated date | 2019-06-08 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2019-06-08 | English | Compare |
| v4 | 2019-06-07 | French | Compare |
| v3 | 2019-06-07 | English | Compare |
| v2 | 2019-04-29 | French | Compare |
| v1 | 2019-04-29 | English | Compare |
Showing 1 to 5 of 5